Arthralgia Global Market Report 2025

Description

Arthralgia refers to pain in one or more joints, usually without inflammation, and can stem from various causes, including infections, autoimmune diseases, or injuries. It is a symptom rather than a standalone condition, often indicating an underlying health issue affecting the joints.

The primary causes of arthralgia include osteoarthritis, rheumatoid arthritis, gout, psoriatic arthritis, lupus, injuries, infections, and other contributing factors. Osteoarthritis is a degenerative joint disease that develops when the protective cartilage cushioning the ends of bones gradually wears down. A range of treatment options is available, including medications, therapies, surgical interventions, and lifestyle or home remedies. These treatments can be administered through different methods, such as oral, injectable, topical, and transdermal routes. They are distributed via hospital pharmacies, retail pharmacies, and online pharmacies and are used across various settings, including hospitals, clinics, home care environments, and rehabilitation centers.

The arthralgia market research report is one of a series of new reports from The Business Research Company that provides arthralgia market statistics, including the arthralgia industry global market size, regional shares, competitors with the arthralgia market share, detailed arthralgia market segments, market trends, and opportunities, and any further data you may need to thrive in the arthralgia industry. This arthralgia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The arthralgia market size has grown strongly in recent years. It will grow from $5.20 billion in 2024 to $5.64 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to the rising prevalence of autoimmune diseases, the increasing incidence of various associated risk factors, the growing rates of obesity, the higher prevalence of arthralgia, and the increasing occurrence of joint disorders.

The arthralgia market size is expected to see strong growth in the next few years. It will grow to $7.73 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period is expected to be driven by increasing awareness of arthralgia, a growing geriatric population, expanding healthcare infrastructure, rising demand for minimally invasive treatments, and the increasing prevalence of sports injuries. Key trends during this period include the integration of digital health solutions, the development of novel therapies and cell therapies, advancements in medical technology, and increased investment in research and development.

The increasing incidence of rheumatoid arthritis is expected to drive the growth of the arthralgia market in the coming years. Rheumatoid arthritis is a chronic autoimmune condition that primarily impacts the joints, causing inflammation, pain, and potential joint damage. The rise in rheumatoid arthritis cases can be attributed to factors such as an aging population, genetic predisposition, lifestyle changes, and environmental factors such as smoking and pollution. Rheumatoid arthritis contributes to arthralgia by causing chronic joint inflammation, leading to pain, stiffness, and progressive damage. For example, in February 2024, Arthritis Australia, a non-profit organization based in Australia, projected that by 2040, arthritis cases in Australia would increase to 5.39 million from 4.11 million in 2025, with rheumatoid arthritis cases reaching 748,721. Consequently, the growing number of rheumatoid arthritis cases is fueling the expansion of the arthralgia market.

Companies in the arthralgia market are focusing on developing innovative treatments, such as RMAT-designated gene therapies, to provide long-term pain relief and improved joint function. RMAT-designated gene therapy refers to a treatment that has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA, which accelerates the development and review of gene therapies for serious or life-threatening conditions. In March 2024, Pacira BioSciences Inc., a US-based pharmaceutical company, received RMAT designation for its product PCRX-201 (enekinragene inzadenovec) from the U.S. Food and Drug Administration (FDA). PCRX-201 is an innovative intra-articular gene therapy candidate designed to treat knee osteoarthritis using a helper-dependent adenovirus (HDAd) to produce interleukin-1 receptor antagonists (IL-1Ra). Pacira emphasized the promising preliminary clinical results, suggesting that PCRX-201 could become a potential disease-modifying treatment for osteoarthritis.

In November 2023, Nevro Corp., a US-based medical device company, acquired Vyrsa Technologies for $75 million. This acquisition allows Nevro to expand its chronic pain treatment portfolio by incorporating Vyrsa Technologies' minimally invasive SI joint fusion devices. By enhancing its market presence, Nevro aims to provide advanced solutions for long-term pain relief to patients suffering from chronic sacroiliac (SI) joint pain. Vyrsa Technologies, a US-based company, specializes in treating arthralgia, specifically addressing chronic SI joint pain.

Major players in the arthralgia market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., UCB S.A., Hikma Pharmaceuticals PLC, Ferring Pharmaceuticals, KD Pharma Group S.A., SI-BONE Inc., Xalud Therapeutics Inc., Incannex Healthcare Limited, Cytonics Corporation, and Vitazan Herbs and Vitamins Inc.

North America was the largest region in the arthralgia market in 2024. The regions covered in arthralgia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the arthralgia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The arthralgia market consists of revenues earned by entities by providing services such as diagnosis services, treatment services, physical rehabilitation programs, and supportive services. The market value includes the value of related goods sold by the service provider or included within the service offering. The arthralgia market also includes sales of musculoskeletal diagnostic tools, biologic drugs, anti-inflammatory drugs, and regenerative therapies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Arthralgia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on arthralgia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for arthralgia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The arthralgia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Cause: Osteoarthritis; Rheumatoid Arthritis; Gout; Psoriatic Arthritis; Lupus; Injuries; Infections; Other Causes
2) By Treatment Type: Medications; Therapies; Surgical Interventions; Lifestyle And Home Remedies
3) By Route Of Administration: Oral; Injectable; Topical; Transdermal
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End User: Hospital; Clinics; Homecare Settings; Rehabilitation Centers
Subsegments:
1) By Osteoarthritis: Knee Osteoarthritis; Hip Osteoarthritis; Hand Osteoarthritis; Spine Osteoarthritis; Shoulder Osteoarthritis
2) By Rheumatoid Arthritis: Seropositive Rheumatoid Arthritis; Seronegative Rheumatoid Arthritis; Juvenile Rheumatoid Arthritis; Early-Onset Rheumatoid Arthritis
3) By Gout: Primary Gout; Secondary Gout; Gouty Arthritis
4) By Psoriatic Arthritis: Symmetric Psoriatic Arthritis; Asymmetric Psoriatic Arthritis; Psoriatic Spondylitis; Distal Interphalangeal Predominant Psoriatic Arthritis
5) By Lupus: Systemic Lupus Erythematosus (SLE); Discoid Lupus Erythematosus; Drug-induced Lupus; Neonatal Lupus
6) By Injuries: Sports-related Injuries; Trauma and Fractures; Sprains and Strains; Tendon or Ligament Damage
7) By Infections: Septic Arthritis; Viral Arthritis; Bacterial Infections; Fungal Infections
8) By Other Causes: Fibromyalgia; Overuse Injuries; Sarcoidosis; Ankylosing Spondylitis; Crystal-induced Arthritis
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; AbbVie Inc.; Sanofi S.A.; Bristol-Myers Squibb Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33970

1. Executive Summary

2. Arthralgia Market Characteristics

3. Arthralgia Market Trends And Strategies

4. Arthralgia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Arthralgia Growth Analysis And Strategic Analysis Framework

5.1. Global Arthralgia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Arthralgia Market Growth Rate Analysis
5.4. Global Arthralgia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Arthralgia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Arthralgia Total Addressable Market (TAM)

6. Arthralgia Market Segmentation

6.1. Global Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Osteoarthritis
Rheumatoid Arthritis
Gout
Psoriatic Arthritis
Lupus
Injuries
Infections
Other Causes
6.2. Global Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medications
Therapies
Surgical Interventions
Lifestyle And Home Remedies
6.3. Global Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
Topical
Transdermal
6.4. Global Arthralgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Arthralgia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Clinics
Homecare Settings
Rehabilitation Centers
6.6. Global Arthralgia Market, Sub-Segmentation Of Osteoarthritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Spine Osteoarthritis
Shoulder Osteoarthritis
6.7. Global Arthralgia Market, Sub-Segmentation Of Rheumatoid Arthritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Seropositive Rheumatoid Arthritis
Seronegative Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Early-Onset Rheumatoid Arthritis
6.8. Global Arthralgia Market, Sub-Segmentation Of Gout, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Primary Gout
Secondary Gout
Gouty Arthritis
6.9. Global Arthralgia Market, Sub-Segmentation Of Psoriatic Arthritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Symmetric Psoriatic Arthritis
Asymmetric Psoriatic Arthritis
Psoriatic Spondylitis
Distal Interphalangeal Predominant Psoriatic Arthritis
6.10. Global Arthralgia Market, Sub-Segmentation Of Lupus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Systemic Lupus Erythematosus (SLE)
Discoid Lupus Erythematosus
Drug-induced Lupus
Neonatal Lupus
6.11. Global Arthralgia Market, Sub-Segmentation Of Injuries, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sports-related Injuries
Trauma and Fractures
Sprains and Strains
Tendon or Ligament Damage
6.12. Global Arthralgia Market, Sub-Segmentation Of Infections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Septic Arthritis
Viral Arthritis
Bacterial Infections
Fungal Infections
6.13. Global Arthralgia Market, Sub-Segmentation Of Other Causes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fibromyalgia
Overuse Injuries
Sarcoidosis
Ankylosing Spondylitis
Crystal-induced Arthritis

7. Arthralgia Market Regional And Country Analysis

7.1. Global Arthralgia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Arthralgia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Arthralgia Market

8.1. Asia-Pacific Arthralgia Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Arthralgia Market

9.1. China Arthralgia Market Overview
9.2. China Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Arthralgia Market

10.1. India Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Arthralgia Market

11.1. Japan Arthralgia Market Overview
11.2. Japan Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Arthralgia Market

12.1. Australia Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Arthralgia Market

13.1. Indonesia Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Arthralgia Market

14.1. South Korea Arthralgia Market Overview
14.2. South Korea Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Arthralgia Market

15.1. Western Europe Arthralgia Market Overview
15.2. Western Europe Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Arthralgia Market

16.1. UK Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Arthralgia Market

17.1. Germany Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Arthralgia Market

18.1. France Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Arthralgia Market

19.1. Italy Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Arthralgia Market

20.1. Spain Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Arthralgia Market

21.1. Eastern Europe Arthralgia Market Overview
21.2. Eastern Europe Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Arthralgia Market

22.1. Russia Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Arthralgia Market

23.1. North America Arthralgia Market Overview
23.2. North America Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Arthralgia Market

24.1. USA Arthralgia Market Overview
24.2. USA Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Arthralgia Market

25.1. Canada Arthralgia Market Overview
25.2. Canada Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Arthralgia Market

26.1. South America Arthralgia Market Overview
26.2. South America Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Arthralgia Market

27.1. Brazil Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Arthralgia Market

28.1. Middle East Arthralgia Market Overview
28.2. Middle East Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Arthralgia Market

29.1. Africa Arthralgia Market Overview
29.2. Africa Arthralgia Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Arthralgia Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Arthralgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Arthralgia Market Competitive Landscape And Company Profiles

30.1. Arthralgia Market Competitive Landscape
30.2. Arthralgia Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Arthralgia Market Other Major And Innovative Companies

31.1. AstraZeneca PLC
31.2. Novartis AG
31.3. GlaxoSmithKline PLC
31.4. Eli Lilly and Company
31.5. Amgen Inc.
31.6. Teva Pharmaceutical Industries Ltd.
31.7. Regeneron Pharmaceuticals Inc.
31.8. Astellas Pharma Inc.
31.9. Biogen Inc.
31.10. UCB S.A.
31.11. Hikma Pharmaceuticals PLC
31.12. Ferring Pharmaceuticals
31.13. KD Pharma Group S.A.
31.14. SI-BONE Inc.
31.15. Xalud Therapeutics Inc.

32. Global Arthralgia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Arthralgia Market

34. Recent Developments In The Arthralgia Market

35. Arthralgia Market High Potential Countries, Segments and Strategies

35.1 Arthralgia Market In 2029 - Countries Offering Most New Opportunities
35.2 Arthralgia Market In 2029 - Segments Offering Most New Opportunities
35.3 Arthralgia Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer